Matches in Wikidata for { <http://www.wikidata.org/entity/Q66395571> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q66395571 description "clinical trial" @default.
- Q66395571 description "ensayu clínicu" @default.
- Q66395571 description "klinisch onderzoek" @default.
- Q66395571 description "клінічне випробування" @default.
- Q66395571 name "A Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Once Daily Mirvaso® Gel in Patients With Chronic Persistent Vascular Facial Erythema." @default.
- Q66395571 name "A Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Once Daily Mirvaso® Gel in Patients With Chronic Persistent Vascular Facial Erythema." @default.
- Q66395571 type Item @default.
- Q66395571 label "A Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Once Daily Mirvaso® Gel in Patients With Chronic Persistent Vascular Facial Erythema." @default.
- Q66395571 label "A Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Once Daily Mirvaso® Gel in Patients With Chronic Persistent Vascular Facial Erythema." @default.
- Q66395571 prefLabel "A Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Once Daily Mirvaso® Gel in Patients With Chronic Persistent Vascular Facial Erythema." @default.
- Q66395571 prefLabel "A Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Once Daily Mirvaso® Gel in Patients With Chronic Persistent Vascular Facial Erythema." @default.
- Q66395571 P1050 Q66395571-1A707429-6308-4A94-BDE8-B4F9977C5730 @default.
- Q66395571 P1132 Q66395571-12091543-51BC-44A7-A85D-887495D14229 @default.
- Q66395571 P1476 Q66395571-88926075-10C8-44E0-8DC4-8D00C872F8FD @default.
- Q66395571 P17 Q66395571-CBF68469-4CB5-4636-9777-2B84C2108079 @default.
- Q66395571 P1813 Q66395571-DD480195-FC2C-4F70-AEB4-390D0BF0614A @default.
- Q66395571 P2899 Q66395571-E8C31461-E93D-4819-BB74-6B9B47740FDD @default.
- Q66395571 P3098 Q66395571-D34623FB-14B3-4BD4-889C-603A4882DBD6 @default.
- Q66395571 P31 Q66395571-E9A234EC-7026-4381-A0F8-963AEE6F6540 @default.
- Q66395571 P580 Q66395571-6CE5D47A-8CB2-4FBA-A6CF-7AE321155385 @default.
- Q66395571 P582 Q66395571-FB6A7F09-1F10-4564-82DE-332CE492C106 @default.
- Q66395571 P6099 Q66395571-88931845-525B-4A4B-A63D-94A6EFE22B1D @default.
- Q66395571 P8363 Q66395571-89BBCE26-8223-445A-9ED3-87A9F8E0B86D @default.
- Q66395571 P1050 Q1166142 @default.
- Q66395571 P1132 "+101" @default.
- Q66395571 P1476 "A Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Once Daily Mirvaso® Gel (5 mg/g Brimonidine Tartrate) in Patients With Chronic Persistent Vascular Facial Erythema." @default.
- Q66395571 P17 Q155 @default.
- Q66395571 P1813 "BR14004" @default.
- Q66395571 P2899 "+18" @default.
- Q66395571 P3098 "NCT02856919" @default.
- Q66395571 P31 Q30612 @default.
- Q66395571 P580 "2016-06-13T00:00:00Z" @default.
- Q66395571 P582 "2017-02-08T00:00:00Z" @default.
- Q66395571 P6099 Q42825046 @default.
- Q66395571 P8363 Q78089383 @default.